{
    "id": "dbpedia_5335_1",
    "rank": 97,
    "data": {
        "url": "https://researchdirectory.uc.edu/p/franklro",
        "read_more_link": "",
        "language": "en",
        "title": "Expert Profile: Robert Franklin",
        "top_image": "https://lcdn.uc.edu/uc-assets/images/favicons/favicon-57x57.png",
        "meta_img": "https://lcdn.uc.edu/uc-assets/images/favicons/favicon-57x57.png",
        "images": [
            "https://researchdirectory.uc.edu/Content/images/logo.png",
            "https://researchdirectory.uc.edu/Content/images/uc-logo-white.png",
            "https://webcentral.uc.edu/eprof/media/repository/0901FranklinRobert6295.jpg",
            "https://researchdirectory.uc.edu/Content/Images/uc-logo-footer.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "",
        "meta_lang": "en",
        "meta_favicon": "//lcdn.uc.edu/uc-assets/images/favicons/favicon-57x57.png",
        "meta_site_name": "",
        "canonical_link": null,
        "text": "Research Support\n\nGrant: #D9723C00001 Investigators:Franklin, Robert 04-08-2024 -04-08-2027 AstraZeneca Pharmaceuticals LP A Randomized, 2-cohort, Double-blind, Placebo-controlled, Phase III Study of AZD5305 in Combination with Physician's Choice New Hormonal Agents in Patients with HRRm and non-HRRm Metastatic Castration Role:PI 0.00 Hold Level:Industry\n\nInvestigators:Franklin, Robert 04-29-2024 -05-29-2024 Myovant Sciences Relugolix Versus Leuprolide in Patients with PRostate Cancer: A Randomized, Open-Label Study to Assess Major Adverse Cardiovascular Events (REPLACE-CV) Role:PI 0.00 Hold Level:Industry"
    }
}